Investor Presentation
Star Health Schedules Investor Meetings
Star Health will hold one-on-one meetings with Mirae Mutual Fund, UTI Mutual Fund and Tata Mutual Fund in Mumbai on November 20, 2026.
Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.


Bearish
2
Neutral
7
Bullish
5
Bearish
21
Neutral
7
Bullish
18

Bearish
19
Neutral
0
Bullish
13
Insurance
General Insurance
33,420 Cr
Low Risk
31.7
14.1
1.5
3.2
624.20
416.85
Sales CAGR
Profit CAGR
ROE
ROCE

Investor Presentation
Star Health will hold one-on-one meetings with Mirae Mutual Fund, UTI Mutual Fund and Tata Mutual Fund in Mumbai on November 20, 2026.
Investor Presentation
Star Health and Allied Insurance will hold one-on-one meetings with five analysts and investors in Mumbai on November 19, 2026.
Investor Presentation
Star Health and Allied Insurance Company will meet analysts and institutional investors at the CLSA Financials Tour in Chennai on November 19, 2026.
Investor Presentation
Star Health will host the JM Financial Annual India Conference on November 17, 2026, in Mumbai, with the meeting presentation available online.
Investor Presentation
Star Health & Allied Insurance Company will meet analysts and institutional investors at the Avendus Spark INDX Annual Conference in Mumbai on November 16, 2026.
Star Health & Allied Insurance Company Ltd (STARHEALTH) is currently trading at 549.00 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.
Star Health and Allied Insurance Company Limited is India's first standalone health insurer, offering retail and group health insurance alongside personal accident and overseas travel products. It distributes policies through a large agency network, digital direct-to-consumer channels, bancassurance, brokers, and other channels, supported by extensive hospital relationships and nationwide customer touchpoints. The company delivered a notable operating turnaround: Q2 FY27 underwriting profit reached Rs. 99 crore versus a Rs. 40 crore loss previously, while H1 underwriting profit of Rs. 210 crore exceeded the entire FY26 result. This marked the fifth consecutive quarter of improving loss ratios and underwriting performance, indicating progress beyond a single-quarter recovery. Growth is increasingly sourced from proprietary distribution, with agency and digital direct-to-consumer channels contributing more than 90% of retail business. Fresh retail health premium grew 35% year-on-year in Q2, the digital channel grew 137% in H1, and 93% of quarterly new customers were entering insurance for the first time. Star Health is pursuing operating leverage through digitalisation and AI. Salesforce improved lead management, AI bots handled over 7.5 million call minutes at under 20% of equivalent human cost, and automated quality assurance reviewed more than 10 million interaction minutes across nine languages. Management expects headline growth to moderate as last year's GST-driven demand enters the comparison base, but targets sustained fresh-business growth above 20%. Its confidence rests on an approximately 80% vintage portfolio, rising multi-year policy penetration, disciplined risk selection, and deeper semi-urban, rural, and younger-customer distribution.
Over the past 52 weeks, Star Health & Allied Insurance Company Ltd has traded between a low of ₹416.85 and a high of ₹624.20. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.
Star Health & Allied Insurance Company Ltd has a market capitalization of approximately 33,419.74. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.
Star Health & Allied Insurance Company Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 31.70 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.
Based on its market capitalization of 33,419.74 Cr, Star Health & Allied Insurance Company Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.
Star Health & Allied Insurance Company Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.
The Price-to-Earnings (PE) ratio of Star Health & Allied Insurance Company Ltd is 31.70. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.
Star Health said its D2C channel grew 137% year on year in H1 FY27. Management identified younger buyers, higher sum insured and non-metro demand as the main contributors to this growth.
Star Health says the proposals fit a retail model in which proprietary agency and D2C channels source over 90% of business. Management particularly highlighted renewal-linked commissions, higher commissions for smaller towns and segment-level agent exclusivity.
Star Health reported underwriting profit of Rs 210 crore in H1 FY27. That compares with an underwriting loss of Rs 24 crore in H1 FY26 and is above the Rs 198 crore profit it delivered in full-year FY26.
Star Health has scheduled its Q2 and H1 FY2027 earnings call for October 28, 2026.